MMSET is the key molecular target in t(4;14) myeloma

Blood Cancer Journal

Volumn 3, Issue 5, 2013, Pages

  Mirabella, F ^a   Wu, P ^a   Wardell, C P ^a   Kaiser, M F ^a   Walker, B A ^a   Johnson, D C ^a   Morgan, G J ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 3; METHYLTRANSFERASE; PROTEIN; PROTEIN MMSET; SMALL NUCLEAR RNA; SMALL NUCLEOLAR RNA; TELOMERASE; UNCLASSIFIED DRUG;

CELL ADHESION; CELL PROLIFERATION; CHROMOSOME 4; EXON; GENE EXPRESSION; GENE MAPPING; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HUMAN; LETTER; MYELOMA; PROMOTER REGION; RNA SEQUENCE; RNA SPLICING; TRANSCRIPTION INITIATION SITE;

EID: 84878304713     PISSN: None     EISSN: 20445385     Source Type: Journal    
DOI: 10.1038/bcj.2013.9     Document Type: Letter

References (15)

1. Chesi M, Nardini E, Lim RS, Smith KD, Kuehl WM, Bergsagel PL. The t(4;14) translocation in myeloma dysregulates both FGFR3 and a novel gene, MMSET, resulting in IgH/MMSET hybrid transcripts. Blood 1998; 92: 3025-3034.
2. Keats JJ, Reiman T, Maxwell CA, Taylor BJ, Larratt LM, Mant MJ et al. In multiple myeloma, t(4;14)(p16;q32) is an adverse prognostic factor irrespective of FGFR3 expression. Blood 2003; 101: 1520-1529.
3. Brito JL, Walker B, Jenner M, Dickens NJ, Brown NJ, Ross FM et al. MMSET deregulation affects cell cycle progression and adhesion regulons in t(4;14) myeloma plasma cells. Haematologica 2009; 94: 78-86.
4. Martinez-Garcia E, Popovic R, Min DJ, Sweet SM, Thomas PM, Zamdborg L et al. The MMSET histone methyl transferase switches global histone methylation and alters gene expression in t(4;14) multiple myeloma cells. Blood 2011; 117: 211-220.
5. Lauring J, Abukhdeir AM, Konishi H, Garay JP, Gustin JP, Wang Q et al. The multiple myeloma associated MMSET gene contributes to cellular adhesion, clonogenic growth, and tumorigenicity. Blood 2008; 111: 856-864.
6. Kuo AJ, Cheung P, Chen K, Zee BM, Kioi M, Lauring J et al. NSD2 links dimethylation of histone H3 at lysine 36 to oncogenic programming. Mol Cell 2011; 44: 609-620.
7. Chu L, Su MY, Maggi Jr. LB, Lu L, Mullins C, Crosby S et al. Multiple myelomaassociated chromosomal translocation activates orphan snoRNA ACA11 to suppress oxidative stress. J Clin Invest 2012; 122: 2793-2806.
8. Kiss T, Fayet E, Jady BE, Richard P, Weber M. Biogenesis and intranuclear trafficking of human box C/D and H/ACA RNPs. Cold Spring Harb Symp Quant Biol 2006; 71: 407-417.
9. Dieci G, Preti M, Montanini B. Eukaryotic snoRNAs: a paradigm for gene expression flexibility. Genomics 2009; 94: 83-88.
10. Tycowski KT, Shu MD, Steitz JA. A mammalian gene with introns instead of exons generating stable RNA products. Nature 1996; 379: 464-466.
11. Hirose T, Shu MD, Steitz JA. Splicing-dependent and -independent modes of assembly for intron-encoded box C/D snoRNPs in mammalian cells. Mol Cell 2003; 12: 113-123.
12. Garlisi CG, Uss AS, Xiao H, Tian F, Sheridan KE, Wang L et al. A unique mRNA initiated within a middle intron of WHSC1/MMSET encodes a DNA binding protein that suppresses human IL-5 transcription. Am J Respir Cell Mol Biol 2001; 24: 90-98.
13. Ronchetti D, Todoerti K, Tuana G, Agnelli L, Mosca L, Lionetti M et al. The expression pattern of small nucleolar and small Cajal body-specific RNAs characterizes distinct molecular subtypes of multiple myeloma. Blood Cancer J 2012; 2: e96.
14. Djebali S, Davis CA, Merkel A, Dobin A, Lassmann T, Mortazavi A et al. Landscape of transcription in human cells. Nature 2012; 489: 101-108.
15. Trapnell C, Roberts A, Goff L, Pertea G, Kim D, Kelley DR et al. Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat Protoc 2012; 7: 562-578.